The Department of Justice has opened an investigation into Andreessen Horowitz over board seat conflicts using a law passed in 1914—and the venture capital industry is scrambling to understand what happens next.
This is the first time the DOJ has invoked the Clayton Act’s interlocking directorate provisions against a venture capital firm. The Clayton Act, enacted more than a century ago to prevent anticompetitive conduct through overlapping corporate boards, was designed for an era of railroad barons and industrial monopolies. Now it’s being applied to one of Silicon Valley’s most powerful investment firms, and the implications ripple far beyond Andreessen Horowitz.
- A Legal First: This marks the first time the DOJ has invoked the Clayton Act’s interlocking directorate provisions against a venture capital firm, signaling a fundamental shift in how antitrust regulators view VC governance.
- The Information Asymmetry: A VC partner holding board seats at competing startups gains simultaneous access to each company’s strategic roadmap, customer base, and financial runway—an advantage that can distort competition even without explicit coordination.
- Industry-Wide Exposure: Legal scholarship has identified private equity and venture capital funds’ interlocking boards as an area warranting serious antitrust scrutiny, suggesting Andreessen Horowitz may be the first of many firms to face this pressure.
The core tension is simple but explosive: venture capitalists at large firms often sit on the boards of multiple portfolio companies that compete with each other. When a VC partner holds board seats at two startups in the same market—say, two AI infrastructure companies or two fintech platforms—they have access to sensitive strategic information from both. They know what one company is building, how much runway it has, who its customers are. Then they walk into a board meeting at the competitor and sit in the same room.
For decades, the VC industry treated this as an unavoidable cost of doing business. Since portfolio companies often pivot and expand into competing markets, investors have long viewed occasional conflicts of interest as an inherent feature of large VC operations. A partner at Andreessen Horowitz might have invested in Company A five years ago when it was a B2B analytics tool, then invested in Company B when it was a consumer app. Three years later, both are competing in the same space. The conflict emerges organically. But the DOJ’s investigation suggests the government no longer accepts that logic.
What Does the Clayton Act Actually Prohibit?
The Clayton Act’s interlocking directorate provisions were written to prevent exactly this scenario. Research examining antitrust enforcement against interlocking directorates traces the law’s origins to 1914, when Congress passed the Clayton Antitrust Act alongside the Federal Trade Commission Act specifically to limit anticompetitive practices that had flourished in the industrial era. Section 8 of the act prohibits officers or directors of one corporation from simultaneously serving on the board of a competing corporation.
The law was meant to stop industrial titans from using board seats to coordinate anticompetitive behavior across rival firms. It has been applied against banks, manufacturers, and retailers. Until now, venture capital has operated in what amounted to a regulatory blind spot. Legal analysis published by Boston University School of Law identifies private equity and venture capital funds’ interlocking boards as an area explicitly worthy of further antitrust scrutiny—a conclusion that now appears to have reached the DOJ’s enforcement agenda.
• The Clayton Act’s Section 8 has been on the books since 1914, but its application to venture capital is effectively unprecedented
• Andreessen Horowitz manages tens of billions in assets with board representation across hundreds of portfolio companies
• The FTC moved against interlocking directorate arrangements as recently as 2023, signaling sustained regulatory interest in the issue across multiple administrations
The precedent for regulatory action is not entirely new. In August 2023, the FTC acted to prevent an interlocking directorate arrangement in the EQT and Quantum Energy deal, citing anticompetitive information exchange as the central concern. That enforcement action established that regulators were prepared to treat shared board access to sensitive competitive information as a standalone antitrust problem—not merely a secondary concern. The DOJ’s current investigation against Andreessen Horowitz extends that logic directly into the venture capital model.
Why Does This Investigation Target the Entire VC Business Model?
What makes this investigation particularly significant is that it targets not just individual board conflicts, but the systematic practice of a major VC firm. Andreessen Horowitz manages tens of billions in assets and has board representation across hundreds of portfolio companies. The firm’s partners don’t just invest capital—they embed themselves in the governance structures of their bets. That level of interlocking influence across a competitive ecosystem is precisely what antitrust law was designed to prevent.
The practical stakes for founders are immediate and uncomfortable. A board seat from a top-tier VC firm has always been worth more than the capital itself. It signals legitimacy to customers, employees, and future investors. It provides access to the firm’s network and operational expertise. But if the DOJ succeeds in forcing Andreessen Horowitz—and potentially other large VCs—to choose between board seats at competing portfolio companies, the value proposition changes. Founders may find their investors less embedded in their governance and with less direct access to the firm’s attention and network.
Conversely, some founders may see this as a relief. A VC partner who sits on the boards of three of your competitors has divided loyalty. They carry fiduciary duties to all of them simultaneously. They cannot fully advocate for your company without potentially violating their obligations to the others. The DOJ’s investigation, in this reading, protects founders from the illusion of undivided investor support.
• Legal scholars have argued that the information flows enabled by interlocking VC boards are structurally similar to the anticompetitive information exchanges the Clayton Act was designed to prevent in industrial markets
• The FTC’s 2023 EQT enforcement action established that regulators view access to competitively sensitive information across rival firms as a harm in itself, independent of any explicit coordination
• If the DOJ prevails, large VC firms may need to develop new governance architectures—including dedicated conflict officers, information barriers between portfolio companies, and formal recusal protocols—to continue operating at scale
The Information Asymmetry Problem: A Familiar Pattern
The timing of this probe also matters. Venture capital has faced mounting scrutiny over the past two years as the industry has consolidated around a smaller number of mega-firms. Andreessen Horowitz, Sequoia, Benchmark, and a handful of others now control enough capital and board seats to shape entire sectors. The DOJ’s Clayton Act investigation suggests the government is beginning to view this concentration as a potential antitrust problem. If a single VC firm can sit on the boards of most of the leading startups in AI, fintech, or biotech, does that firm have the power to coordinate behavior across those companies, even if unintentionally?
The structure parallels a different kind of information asymmetry that emerged in the Cambridge Analytica scandal. In that case, a single firm harvested behavioral data across millions of users and used that information to influence outcomes in multiple political races simultaneously. As documented in analyses of how Cambridge Analytica exposed the business of human data, the power came from aggregating information across supposedly separate domains and using it to shape behavior at scale. Here, the mechanism is different—board seats instead of data profiles—but the underlying concern is structurally similar: a central node with privileged access to sensitive information across competing entities.
A VC partner with board seats at five competing startups has something like a panopticon view of an entire market. They see which companies are gaining traction, which are struggling, what each is building next. That information advantage, even if never explicitly weaponized, creates an asymmetry that can distort competition. The legacy of Cambridge Analytica demonstrated that concentrated information access does not require malicious intent to produce harmful outcomes—the architecture of the advantage is itself the problem.
What Happens If the DOJ Prevails?
The DOJ hasn’t yet filed charges or made public statements about what specific conduct it’s investigating. The investigation itself is the news. But the Clayton Act gives the government clear legal tools. If the DOJ determines that Andreessen Horowitz’s board interlocks constitute a violation, it can seek an injunction forcing the firm to divest from certain board seats. It can impose restrictions on future board appointments. It can demand structural changes to how the firm manages conflicts of interest.
For the broader VC industry, this is a watershed moment. Smaller firms and emerging managers may actually benefit—if large VCs are forced to reduce their board seat portfolios, they’ll have fewer seats to offer, and founders may look elsewhere. But for the mega-firms, the investigation signals that the era of unlimited board interlocking is over. They’ll need to develop new governance structures, clearer conflict policies, and possibly new ways to add value to portfolio companies without sitting on every board.
The real question is whether the DOJ will stop at Andreessen Horowitz or whether this is the opening move in a broader antitrust campaign against concentrated VC power. If other firms face similar investigations, the entire business model of large venture capital could shift. Board seats have been the currency of VC influence for fifty years. The Clayton Act investigation suggests that currency is about to become much more expensive to spend—and that the information advantages it confers are no longer invisible to regulators.
